{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:04:11Z","timestamp":1785416651092,"version":"3.56.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:03:25Z","timestamp":1785413005000},"page":"931-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conditioning, Donor, and Genotype: Hematopoietic Cell Transplantation for Malignant Infantile Osteopetrosis in 2026"],"prefix":"10.1016","volume":"32","author":[{"given":"Polina","family":"Stepensky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtct.2026.07.008_bib0001","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/S2666-6367(23)00368-8","article-title":"Bone marrow transplantation in malignant infantile osteopetrosis: Reporting 25 years of experience from a tertiary care hospital","volume":"29","author":"AlSaedi","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2026.07.008_bib0002","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jtct.2026.04.046","article-title":"Hematopoietic stem cell transplantation in infantile osteopetrosis: Lessons from a resource-limited setting","volume":"32","author":"Khan","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2026.07.008_bib0003","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1704194","article-title":"Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report","volume":"32","author":"Driessen","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.008_bib0004","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/pbc.25801","article-title":"Improved outcomes of hematopoietic stem cell transplantation in patients with infantile malignant osteopetrosis using fludarabine-based conditioning","volume":"63","author":"Natsheh","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2026.07.008_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood-2025-165","article-title":"Hematopoietic stem cell transplantation in 746 children with osteopetrosis: a study of the Inborn Errors Working Party of the EBMT","volume":"146","author":"Chiesa","year":"2025","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.07.008_bib0006","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41409-020-01040-9","article-title":"Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases","volume":"56","author":"Even-Or","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.008_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28841","article-title":"How we approach malignant infantile osteopetrosis","volume":"68","author":"Even-Or","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2026.07.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116229","article-title":"Clinical presentation and analysis of genotype-phenotype correlations in patients with malignant infantile osteopetrosis","volume":"154","author":"Even-Or","year":"2022","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.jtct.2026.07.008_bib0009","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID Inborn Errors Working Party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.008_bib0010","unstructured":"A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects with Infantile Malignant Osteopetrosis. ClinicalTrials.gov identifier NCT04525352. Status: terminated (study discontinued due to feasibility). Accessed June 9, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04525352"},{"key":"10.1016\/j.jtct.2026.07.008_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1450349","article-title":"Correction of osteopetrosis in the neonate oc\/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning","volume":"15","author":"Penna","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jtct.2026.07.008_bib0012","unstructured":"Clinical gene therapy trial for autosomal recessive osteopetrosis. IRCCS San Raffaele Scientific Institute and Fondazione Telethon, Milan, Italy. EU Clinical Trials Information System identifier EU CT 2024-518972-30."},{"key":"10.1016\/j.jtct.2026.07.008_bib0013","article-title":"Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications","author":"Zonari","year":"2026","journal-title":"bioRxiv"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:37:06Z","timestamp":1785415026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726005403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666636726005403"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.008","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditioning, Donor, and Genotype: Hematopoietic Cell Transplantation for Malignant Infantile Osteopetrosis in 2026","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}